CASIA OpenIR

浏览/检索结果: 共4条,第1-4条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy 期刊论文
CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 15, 页码: 3583-3592
作者:  Song, Jiangdian;  Shi, Jingyun;  Dong, Di;  Fang, Mengjie;  Zhong, Wenzhao;  Wang, Kun;  Wu, Ning;  Huang, Yanqi;  Liu, Zhenyu;  Cheng, Yue;  Gan, Yuncui;  Zhou, Yongzhao;  Zhou, Ping;  Chen, Bojiang;  Liang, Changhong;  Liu, Zaiyi;  Li, Weimin;  Tian, Jie
Adobe PDF(1305Kb)  |  收藏  |  浏览/下载:438/100  |  提交时间:2018/10/10
EGFR-TKI therapy  
Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments 期刊论文
CANCER LETTERS, 2018, 卷号: 414, 期号: 414, 页码: 230-238
作者:  Du, Yang;  Liang, Xiaolong;  Li, Yuan;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
Adobe PDF(3002Kb)  |  收藏  |  浏览/下载:580/240  |  提交时间:2018/01/03
Programmed Cell Death Ligand-1  Near Infrared Fluorescence  Magnetic Resonance Imaging  Paclitaxel  Chemotherapy  Immunotherapy  
Cerenkov luminescence imaging on evaluation of early response to chemotherapy of drug-resistant gastric cancer 期刊论文
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 卷号: 14, 期号: 1, 页码: 205-213
作者:  Liu, Muhan;  Zheng, Sheng;  Zhang, Xiaojun;  Guo, Hongbo;  Shi, Xiaojing;  Kang, Xiaoyu;  Qu, Yawei;  Hu, Zhenhua;  Tian, Jie
浏览  |  Adobe PDF(2275Kb)  |  收藏  |  浏览/下载:516/181  |  提交时间:2018/01/02
Apoptosis  Cerenkov Luminescence Imaging  Vincristine-resistance  Gastric Cancer  Cisplatin  
Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation 期刊论文
BIOMATERIALS, 2016, 卷号: 87, 页码: 46-56
作者:  Ma, Xibo;  Hui, Hui;  Jin, Yushen;  Dong, Di;  Liang, Xiaolong;  Yang, Xin;  Tan, Ke;  Dai, Zhifei;  Cheng, Zhen;  Tian, Jie
浏览  |  Adobe PDF(3020Kb)  |  收藏  |  浏览/下载:537/128  |  提交时间:2016/04/06
Antibody Therapy  Gold Nanoparticles  Hepatocellular Carcinoma  Cell Proliferation  Bioluminescence Tomography